Market Seasonality: Dispelling the Myth of August and September Weakness
Finance

Market Seasonality: Dispelling the Myth of August and September Weakness

authorBy David Rubenstein
DateAug 03, 2026
Read time2 min

Conventional wisdom often suggests that financial markets experience a seasonal lull, particularly in late summer and early autumn. For decades, investors have eyed August and September with a degree of caution, bracing for potential downturns based on historical S&P 500 performance. However, recent market behavior signals a potential divergence from these entrenched patterns, prompting a reconsideration of how much weight seasonality should carry in modern investment decisions. This analysis explores the enduring legacy of market seasonality, its historical foundations, and the evolving landscape that challenges its predictive power.

Market Performance: Challenging Seasonal Norms for August and September

Mike Larson, a notable commentator from MoneyShow, highlights a significant shift in market dynamics, noting that seasonal tailwinds, which once offered a predictable boost or drag to portfolios, are no longer as reliable. The long-held belief that August and September are perilous months for stock market performance is being tested by contemporary trends. Historically, data compiled by Visual Capitalist for the S&P 500 Index, stretching back three-quarters of a century, firmly placed August as the second-weakest month, tied with February, and unequivocally labeled September as the weakest. This historical perspective, encapsulated in the 'MoneyShow Chart of the Day,' has guided investment strategies for generations, prompting many to reduce exposure or adopt defensive positions during these periods. However, recent market cycles, including an unexpected 3.5% gain in September 2025, suggest that while historical seasonality provides a framework, it is not an infallible determinant of future market movements. This calls for investors to scrutinize whether traditional seasonal patterns continue to hold sway or if the market has entered a new phase where other factors exert greater influence.

The notion of market seasonality, particularly the "September Effect," has been a cornerstone of market folklore and strategic planning for many investors. While historical data offers a compelling narrative of underperformance during these months, modern markets are increasingly complex and influenced by a myriad of global factors, technological advancements, and shifting investor behaviors. Therefore, a rigid adherence to past seasonal trends might overlook emerging opportunities or misinterpret current signals. The article prompts a vital discussion: to what extent should investors remain tethered to historical patterns when the present market demonstrates a capacity to defy them? Perhaps a more dynamic and adaptive approach to investment strategy, one that acknowledges historical context but prioritizes real-time indicators, is increasingly necessary in today's fast-evolving financial landscape.

More Articles
Finance
Ripple's Strategic Investment in ZILO and Licuido Strengthens XRP Ledger Ecosystem
Ripple has made significant investments in UK-based firms ZILO and Licuido to enhance the XRP Ledger's capabilities. These strategic moves introduce robust regulated record-keeping, issuance, and collateral management tools, crucial for integrating traditional finance with blockchain technology. While the new partnerships expand the XRP Ledger's infrastructure, they are primarily focused on stablecoin-based transactions, meaning direct demand for XRP remains limited to network fees.
By Fareed ZakariaAug 03, 2026
Finance
Alto Neuroscience's Promising Pipeline and Financial Strength Bolster 'Buy' Rating
Alto Neuroscience maintains a 'Buy' rating due to the significant potential of ALTO-207 for treatment-resistant depression (TRD) and its robust financial position. Despite a previous phase 2b setback with ALTO-100, the company's diverse pipeline and biomarker-driven strategies instill confidence. With $264.2 million in cash, Alto Neuroscience is well-funded to achieve crucial clinical milestones and pursue a New Drug Application (NDA) through 2029.
By Michele FerreroAug 03, 2026
Finance
Navigating Market Dynamics: AI's Impact and Strategic Software Investments
This report details Bretton Fund's Q2 2026 performance, highlighting the successful turnaround of UnitedHealth and the continued strength of Alphabet amidst a market surge driven by AI data center investments. The fund expresses caution regarding the sustainability of current AI hardware spending and introduces new strategic positions in SAP and Constellation Software, emphasizing their resilience against perceived AI disruption.
By Morgan HouselAug 03, 2026
Finance
Janus Henderson Asset-Backed Securities ETF: A Strong Buy for Yield and Stability
The Janus Henderson Asset-Backed Securities ETF (JABS) remains a compelling 'Buy' due to its attractive risk-adjusted yield and defensive investment strategy. The ETF primarily invests in high-grade asset-backed securities, predominantly rated single-A and AA, maintaining a short duration of approximately two years and minimal exposure to lower-rated BBB assets. This structure ensures a low default risk profile. JABS offers a 4.8% SEC yield, outperforming Treasury bills, and has demonstrated exceptional stability with a maximum drawdown of only -1%. While susceptible to spread widening during severe recessions, anticipated drawdowns are modest, and the yield effectively offsets potential losses.
By Morgan HouselAug 03, 2026
Finance
Hirschmann Capital's Q1 2026 Report: Navigating Global Economic Headwinds with an Ultra-Bearish Strategy
Hirschmann Capital's latest report reveals a robust performance for Class A and B funds in H1 2026, despite their ultra-bearish stance. The report delves into concerns over the U.S. fiscal outlook, the vulnerabilities of housing and equity markets, and the potential impact of China's economic slowdown on global growth. It also highlights the strategic importance of gold mining equities (GMEs) as a hedge against a potential U.S. sovereign debt crisis, underscoring their attractive valuation and diversification benefits.
By Fareed ZakariaAug 03, 2026